11-10455429-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001025389.2(AMPD3):​c.-25C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0003 in 972,178 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

AMPD3
NM_001025389.2 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.21

Publications

0 publications found
Variant links:
Genes affected
AMPD3 (HGNC:470): (adenosine monophosphate deaminase 3) This gene encodes a member of the AMP deaminase gene family. The encoded protein is a highly regulated enzyme that catalyzes the hydrolytic deamination of adenosine monophosphate to inosine monophosphate, a branch point in the adenylate catabolic pathway. This gene encodes the erythrocyte (E) isoforms, whereas other family members encode isoforms that predominate in muscle (M) and liver (L) cells. Mutations in this gene lead to the clinically asymptomatic, autosomal recessive condition erythrocyte AMP deaminase deficiency. Alternatively spliced transcript variants encoding different isoforms of this gene have been described. [provided by RefSeq, Jul 2008]
AMPD3 Gene-Disease associations (from GenCC):
  • adenosine monophosphate deaminase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMPD3NM_001025389.2 linkc.-25C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 15 ENST00000396553.7 NP_001020560.1 Q01432-1
AMPD3NM_001025389.2 linkc.-25C>T 5_prime_UTR_variant Exon 1 of 15 ENST00000396553.7 NP_001020560.1 Q01432-1
AMPD3NM_000480.3 linkc.22+4386C>T intron_variant Intron 1 of 14 NP_000471.1 Q01432-4
AMPD3NM_001172431.2 linkc.-278+4914C>T intron_variant Intron 1 of 13 NP_001165902.1 Q01432-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMPD3ENST00000396553.7 linkc.-25C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 15 1 NM_001025389.2 ENSP00000379801.2 Q01432-1
AMPD3ENST00000396553.7 linkc.-25C>T 5_prime_UTR_variant Exon 1 of 15 1 NM_001025389.2 ENSP00000379801.2 Q01432-1

Frequencies

GnomAD3 genomes
AF:
0.00142
AC:
209
AN:
146880
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00498
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000470
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000488
GnomAD4 exome
AF:
0.000101
AC:
83
AN:
825138
Hom.:
0
Cov.:
38
AF XY:
0.000110
AC XY:
42
AN XY:
381222
show subpopulations
African (AFR)
AF:
0.00364
AC:
57
AN:
15652
American (AMR)
AF:
0.00
AC:
0
AN:
970
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
5098
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3604
South Asian (SAS)
AF:
0.0000615
AC:
1
AN:
16268
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
280
Middle Eastern (MID)
AF:
0.000623
AC:
1
AN:
1604
European-Non Finnish (NFE)
AF:
0.0000239
AC:
18
AN:
754618
Other (OTH)
AF:
0.000222
AC:
6
AN:
27044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00142
AC:
209
AN:
147040
Hom.:
1
Cov.:
31
AF XY:
0.00128
AC XY:
92
AN XY:
71764
show subpopulations
African (AFR)
AF:
0.00496
AC:
201
AN:
40528
American (AMR)
AF:
0.000470
AC:
7
AN:
14906
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3412
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4638
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4290
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9462
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66562
Other (OTH)
AF:
0.000483
AC:
1
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000925
Hom.:
0
Bravo
AF:
0.00151
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Erythrocyte AMP deaminase deficiency Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
14
DANN
Benign
0.92
PhyloP100
-1.2
PromoterAI
-0.026
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs576679601; hg19: chr11-10476976; API